S100A2 and Huntington disease: To characterize neoplastic cell phenotypes in PDAC-HD samples, we performed immunofluorescence (IF) staining using validated antibodies to GATA6, HNF1A, KRT5, KRT17, KRT81 and S100A2 (Fig. 3a–c and Supplementary Table 13).